Hunter Smith
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $540,477 | $6,228,429 |
| 2024 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $499,385 | $5,050,410 |
| 2023 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $476,154 | $2,308,007 |
| 2022 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $460,000 | $1,215,125 |
| 2021 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $435,957 | $2,309,413 |
| 2020 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $416,118 | $2,662,468 |
| 2019 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer | $393,992 | $1,922,853 |
| 2018 | Rhythm Pharmaceuticals, Inc. (RYTM) | Chief Financial Officer, Treasurer, Secretary and Interim President and Chief Executive Officer | $387,600 | $1,587,137 |
Earnings-call appearances
-
Canaccord Genuity 46th Annual Growth Conference2026-08-12
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call2026-08-04
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-05
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-26
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-04
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-05
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-07
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-10
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-05
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-06
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-07
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-22
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-07
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-01
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-02
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-01
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-08
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-02
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-03
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-03-01
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-02
Rhythm Pharmaceuticals, Inc. (RYTM)
-
Rhythm Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-03
Rhythm Pharmaceuticals, Inc. (RYTM)